Pfizer funding trail raises questions over vaccine exemption campaign

A $500,000 funding trail disclosed by pharmaceutical giant Pfizer has come under scrutiny after two nonprofit organisations that received the company’s grants later joined a coalition urging Massachusetts lawmakers to scrap the religious exemption from mandatory school vaccination requirements.

Pfizer’s 2024 grant records show payments totalling $500,000 to the organisations, while a June 2026 advocacy letter lists both among groups calling for legislative action to remove the exemption.

The funding was disclosed by Pfizer as part of its transparency programme, which the pharmaceutical company says covers grants and charitable contributions to medical, scientific, patient and civic organisations. Pfizer also states that such funding is not intended to influence specific legislation or government healthcare policies.

On June 1, 2026, ASMP and March of Dimes were among organisations that signed a coalition letter to the Massachusetts House Committee on Ways and Means supporting House Bill 2554 (H.2554).

The letter called for passage of the bill, which would eliminate the state’s non-medical exemption from school vaccination requirements and introduce expanded reporting of student immunisation and exemption data. ASMP’s Patti Wukovits and Alicia Stillman and March of Dimes’ Chloe Schwartz were listed among the signatories.

Massachusetts law currently permits a child to receive a religious exemption from school vaccination requirements, except during an emergency or epidemic declared by the state Department of Public Health. Medical exemptions remain separately available.

READ ALSO; Ex-Pfizer executive revives debate over COVID-19 vaccine safety, risks

H.2554 would amend the law by removing the religious exemption while requiring public, private and charter K-12 schools to report aggregate immunisation and exemption figures to the Department of Public Health.

The Massachusetts legislature’s records show that the bill was reported favorably by the House Committee on Public Health in July 2025, later moved through the Health Care Financing Committee, and on April 15, 2026, was recommended to pass and referred to the House Committee on Ways and Means. It remains listed as referred to Ways and Means.

Supporters of the legislation, including organisations represented in the June coalition, argue that removing non-medical exemptions could improve vaccination coverage and reduce the risk of outbreaks. The coalition letter cited rising use of non-medical exemptions and concerns over school-level immunisation rates.

Opponents, meanwhile, have raised concerns about religious freedom, parental choice and the consequences for families whose children cannot meet school vaccination requirements without a non-medical exemption.

The funding disclosures, however, do not establish that either Pfizer grant was specifically intended to influence H.2554 or Massachusetts’ religious-exemption policy. Pfizer’s stated purposes were broader vaccine-policy initiatives relating to meningococcal vaccination and maternal immunisation.

The overlap between the disclosed funding and subsequent advocacy has nevertheless prompted questions from critics about potential conflicts of interest when pharmaceutical companies financially support organisations that later participate in campaigns concerning vaccine policy.

The issue is therefore centred on transparency and the relationship between industry funding and public-policy advocacy, rather than evidence that Pfizer directly financed lobbying for H.2554.